The investment company Transformica is the new main owner of Lytics with 57% of the shares.
”We see Lytics Health as an exciting company with great development potential for a market that we believe will open up in the near future. Lytics’ board of directors and management have done a good job of targeting the technology to help patients with chronic diseases and are now in a leading position. We believe in the field and, with our experience and good industry knowledge and the right contact network to lead the company to further success”, says Jim Larsson, CEO of Transformica.
Today is the start date of the exciting new project ”AD Shield – presymptomatic Alzheimer’s disease detection & prevention of citizens at high risk”. The project will run for 24 months and is co-founded by Eureka member countries and the European Union Horizon 2020 Framework Programme.
On September 13th Daniel Hamngren, Senior Data Scientist and Team Leader, held a presentation called Actionable Insights in Dialysis Care at the Nordic.ai Health Summit conference.
The presentation was about a project that is part of Lytics' collaboration with Centers for Dialysis Care in Cleveland, where Lytics makes predictions on 2000 patients that have End Stage Renal Disease and need regular dialysis treatments in order to survive.
On September the 27th, Mattias Paulsson, Partner and CEO, will hold a presentation at the Park Annual Conference at Sahlgrenska Science Park in Gothenburg.
The presentation “Predictive healthcare for chronic diseases with machine learning” will be about the results from a trial in the dialysis field and Mattias will share our experiences of how technology can reengineer preventive workflows in healthcare and contribute to sustainability.
Lytics is pleased to be presenting at the Anglonordic Life Science Conference today on the 24th of May. We will be discussing our work and developments within predictive healthcare for chronic diseases and our clinical decision support system VÖR®, which uses artificial intelligence to predict and prevent hospitalizations of end stage renal disease patients.
Innovation Skåne and HealthTech Nordic organize a workshop at Vitalis 2018. The workshop gathers companies and individuals that collectively carry experiences and solutions to remove obstacles for digital health care. See you in the exhibition hall at booth B02:11
Lytics has recently been selected for the Bridge Market Check program which consists of a collaboration with Sahlgrenska Science Park and Business Sweden. The program has a focus on helping Swedish Med Tech companies enter the UK market, and the collaboration grants Lytics access to a broad network within the UK market, as well as in depth analyses and understandings of how the market functions.